Long-Term Efficacy of Zanubrutinib Confirmed for Mantle Cell Lymphoma
The safety profile remained similar to earlier analyses, with the most common grade 3 or higher adverse events including neutropenia and pneumonia.
Hematologic Cancers
Prevalence of Frailty in Patients With MPNs Linked to Subtype
Researchers sought to determine the prevalence of frailty among patients with myeloproliferative neoplasms.
Biomarkers May Help Guide Treatment in Cancer Patients With COVID-19
Three biomarkers were associated with prognosis after COVID-19 treatment.
Decision Aid Tool Helps Survivors of Lymphoma to Understand Implications of Lung Cancer Screening
Researchers sought to determine whether a decision aid tool could help survivors of Hodgkin lymphoma understand lung cancer screening.
How Can Multiple Myeloma Affect a Patient’s Lifestyle?
Multiple myeloma (MM) forms in a patient’s plasma cells, and the symptoms it brings can affect their quality of life in ways they may not be thinking about when first diagnosed. What are some lifestyle factors that are affected by multiple myeloma, and how can you discuss managing them with your patients?
Change in Health Behaviors Affect Quality of Life in Lymphoma Survivors
Baseline alcohol consumption was associated with a higher QOL score compared with never use of alcohol.
Adding Elotuzumab to Myeloma Treatment Regimens Does Not Improve Outcomes
Predictors of worse progression-free survival included ISS stage II, ISS stage III, and adverse cytogenetics.
How Can Lifestyle Factors Affect Myeloproliferative Neoplasms?
As myeloproliferative neoplasms (MPN) are a particularly rare form of blood cancer without a clear cause, it may be difficult to understand how lifestyle factors can affect both MPN risk and symptom burden. What has research suggested about the ways certain lifestyle factors affect MPNs?
COVID-19: What Do We Know About Outcomes in Hematologic Malignancies?
Patients with hematologic malignancies are at an advanced risk when they also have COVID-19. What have some recent studies suggested about outcomes in patients who have both?
Myeloproliferative Neoplasms: How Do MPNs Affect Quality of Life?
As myeloproliferative neoplasms (MPNs) are a rare form of blood cancer, patients may not be aware of its effects. How do MPNs affect a patient’s quality of life, and what do your patients need to know?
- Loading...
Loading...
Next post in Myelodysplastic Syndromes
Loading... 
Loading...